Complication rate
8.00%
Range 5.00–12.00%
n=2 studies
This page contains health-related information for reference only. It is not medical advice. Read full disclaimer
weight loss
Roux-en-Y gastric bypass is a bariatric surgery that creates a small gastric pouch (typically 15-30ml) and bypasses most of the stomach and proximal small intestine. The procedure has two mechanisms: restriction (small pouch reduces meal volume) and malabsorption (bypassed proximal small bowel reduces nutrient absorption). RYGB produces typically greater weight loss than sleeve gastrectomy in many series, better resolution of type 2 diabetes and reflux disease, and a more durable long-term result — at the cost of technical complexity, higher early-complication rate, more demanding lifelong nutritional supplementation, and a small ongoing risk of internal hernia.
RYGB was developed in the 1960s and refined into its modern laparoscopic form in the 1990s. It is considered the long-standing gold standard for bariatric surgery and is supported by Cochrane review data showing durable weight loss and metabolic disease resolution. Sleeve gastrectomy has overtaken RYGB in absolute numbers worldwide due to its lower technical complexity, but RYGB remains the procedure of choice for patients with severe reflux, Barrett's oesophagus, or strong metabolic indications.
RYGB is typically priced 10-25% above sleeve gastrectomy at the same centre due to longer operative time, more staple loads, and a slightly longer hospital stay. Quoted prices usually cover the procedure, ICU/HDU stay if needed, 2-4 nights ward stay, all in-hospital medications, and immediate follow-up. Long-term nutritional supplementation, follow-up bloods, and any revision surgery are typically additional.
Complication rate
8.00%
Range 5.00–12.00%
n=2 studies
Revision rate
7.00%
Range 3.00–12.00%
n=1 study
Mortality rate
0.30%
Range 0.10–0.50%
n=1 study
Aggregated from peer-reviewed systematic reviews on PubMed. How we extract these rates.
Other clinically reasonable options for the same condition. The right alternative depends on the patient's specific anatomy, comorbidities, and goals — discuss with a treating clinician rather than self-selecting from this list.
Simpler procedure with fewer nutritional risks; slightly less long-term weight loss.
Source ASMBS — Clinical Practice Guidelines for Metabolic and Bariatric Surgery
Greatest weight loss + diabetes remission, highest nutritional-deficiency risk.
Source ASMBS — Clinical Practice Guidelines for Metabolic and Bariatric Surgery
Single-anastomosis duodenal switch; near-equivalent weight loss with lower complication rate.
Source ASMBS — Clinical Practice Guidelines for Metabolic and Bariatric Surgery
GLP-1 receptor agonists
Pharmacological route now achieving meaningful weight loss; combination therapy may be appropriate.
Source ASMBS — Clinical Practice Guidelines for Metabolic and Bariatric Surgery
Specialty-board certifications and facility-level accreditations relevant to this procedure. Verify on the issuer's public register before booking — most issuers publish a searchable directory.
IFSO Centre of Excellence
Issuer International Federation for the Surgery of Obesity
Facility + surgical-team accreditation for bariatric surgery; requires minimum case volumes, multidisciplinary follow-up, and outcomes reporting.
Verify on the issuer's register →ASMBS MBSAQIP Accredited Bariatric Center
Issuer American Society for Metabolic and Bariatric Surgery + American College of Surgeons
US-specific facility accreditation requiring case-volume thresholds, structured follow-up, and outcomes data submission.
Verify on the issuer's register →JCI hospital accreditation
Issuer Joint Commission International
Facility-level standards covering patient safety, infection control, governance, and clinical quality. Required by many medical-tourism intermediaries before listing a hospital.
Verify on the issuer's register →Average recovery for Roux-en-Y Gastric Bypass is 21 days. Individual recovery varies — always follow your surgeon’s specific guidance.
Immediate
First 24–48 hours post-procedure. Monitoring, anaesthesia recovery, initial pain management. Most clinics expect you to remain on-site or nearby.
Early recovery
Wound care, swelling or bruising peaks, restricted activity. Typical window for follow-up visits and drain removal if applicable. Travel is usually not advised.
Intermediate recovery
Gradual return to non-strenuous daily activity. Many international patients fly home during this window. Surgeon may require medical clearance for long-haul travel.
Full recovery
Return to full activity, exercise, and work. Final results may still be settling. Final follow-up with local doctor recommended.
Day 0: procedure completed laparoscopically in 90-180 minutes. ICU or step-down monitoring overnight. Pain control with regional and systemic analgesia. NPO (nil by mouth) with IV fluids.
Day 1: transfer to ward. Mobilisation. Sips of water if not vomiting. Continued DVT prophylaxis.
Day 2-4: progression to clear liquids, then pureed diet. Discharge typically at day 3-4. Dietary advice from a bariatric dietitian.
Week 1-4: pureed and soft-textured foods. Walking and gentle activity. Continued anti-emetics, PPIs, and supplements.
Week 4-8: gradual return to solid foods. Smaller meal portions essential — pouch capacity is roughly 60-120ml. Slower eating, careful chewing.
Month 3-6: most patients establish their long-term eating pattern. Significant weight loss visible. Excess skin issues may begin in some patients.
Month 12-18: peak weight loss typically reached. Maintenance phase begins. Continued lifelong follow-up with bariatric team or substitute home services.
RYGB requires careful coordination with home-country medical services for lifelong follow-up. International patients should plan for 7-10 days locally before flying long-haul, with DVT prophylaxis (RYGB carries substantial DVT risk). A clear handover plan to home-country bariatric services for nutritional surveillance, weight-loss support, and management of any long-term complications is essential — RYGB is the most follow-up-dependent of the common bariatric procedures.
Lifelong supplementation (B12, iron, calcium, multivitamin) is non-negotiable. Confirm that the prescriptions are available in your home country (most are) and that your home GP is willing to provide ongoing surveillance bloods.
Bar length shows how many clinics in our registry offer roux-en-y gastric bypass in each country. Shading shows the verification status mix. International price range is $11,000–$26,000 USD across all countries; we do not currently hold per-country clinic pricing suitable for side-by-side comparison.
Browse all destinations offering Roux-en-Y Gastric Bypass→
3 clinics in our registry
Verified
Accreditations, corporate registration, and published reviews independently checked against primary sources.
Partially verified
Some fields confirmed from primary sources; others self-reported by the clinic and awaiting verification.
Unverified
Listing is based on public information but has not yet been independently verified against primary sources.
Flagged
Credible concerns identified. Red flags are documented on the clinic page. We never soften or remove warnings.
Monterrey, Mexico·Est. 1969·Verified this week
A JCI-accredited teaching hospital in Monterrey affiliated with Tecnológico de Monterrey. The hospital offers general surgery including laparoscopic hernia repair and bariatric procedures within a university hospital setting.
Tijuana, Mexico·Est. 2011·Verified 2y ago
A bariatric surgery centre in Tijuana near the US-Mexico border, specialising in gastric sleeve procedures for American and Canadian patients. The centre's lead surgeon is board-certified by the Mexican Board of General Surgery and a member of the American Society for Metabolic and Bariatric Surgery.
Tijuana, Mexico·Est. 2009·Verified 2y ago
A bariatric surgery centre in Tijuana specialising in gastric sleeve and revision procedures. Designated a Centre of Excellence by the Surgical Review Corporation. The centre operates a dedicated post-operative recovery suite adjacent to the surgical facility.
RYGB is typically preferred for patients with severe reflux, Barrett's oesophagus, or strong metabolic indications (severe type 2 diabetes). Sleeve is typically preferred for patients without those indications, particularly first-time bariatric patients seeking a simpler, technically lower-risk procedure. A multidisciplinary team decision is standard.
Typical excess weight loss at 2 years after RYGB is 65-80%. Sustained weight loss at 10 years is 50-65%. Individual variation is substantial — long-term success correlates strongly with adherence to dietary and lifestyle change after the procedure.
Dumping syndrome occurs when high-sugar food enters the small bowel rapidly through the small gastric pouch. Symptoms include nausea, sweating, palpitations, abdominal cramping, and weakness, usually 15-30 minutes after eating. It is largely preventable by avoiding concentrated sweets and following dietary guidance.
Yes — lifelong supplementation with B12, iron, calcium, vitamin D, and a multivitamin is universal advice after RYGB because the bypassed proximal small bowel is where most micronutrient absorption occurs. Annual surveillance bloods are essential.
An internal hernia is a complication unique to bypass procedures: small bowel can twist through one of the mesenteric defects created during surgery, causing obstruction. Rates have fallen with the widespread practice of mesenteric defect closure but remain a lifetime risk (1-5%). Symptoms include new-onset cramping abdominal pain, particularly after meals.
Technically yes, but reversal is a major operation rarely performed and rarely indicated. RYGB should be considered a permanent decision.
Previous abdominal surgery is not a contraindication but can make laparoscopic access more challenging due to adhesions. The surgeon may convert to open surgery intra-operatively if safe laparoscopic access is not feasible. Pre-operative imaging to map any anticipated adhesions is sometimes performed.
Yes — bypass alters the absorption of some medications because the proximal small bowel (the main absorption site for many oral drugs) is bypassed. Extended-release formulations are commonly switched to immediate-release equivalents. Certain medications (e.g. some antifungals, thyroid hormone) may require dose adjustment based on serum-level monitoring.
Glossary entries associated with roux-en-y gastric bypass
Roux-en-Y Gastric Bypass is a variant of Gastric Sleeve (Sleeve Gastrectomy). See the parent procedure for the broader category context.
Other weight loss procedures in our registry